Press release
Biological Drugs Market to Reach US$452.64 Bn in 2025, Eyes US$1,029.20 Bn by 2032, Says Persistence Market Research
Biological Drugs Market
The oncology segment is projected to remain the leading therapeutic area with a share of around 44.3% in 2025, primarily due to the global rise in cancer cases and the availability of breakthrough immunotherapies. Geographically, North America dominates the market with about 36.7% share in 2025, backed by strong regulatory frameworks, robust healthcare infrastructure, and substantial R&D spending. Asia Pacific, however, is set to emerge as the fastest-growing region, boasting an expected CAGR of 11.5% through 2032, led by large patient pools and rising government support for biologics development.
Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/2883
Key Highlights from the Report
• The global biological drugs market is projected to grow at a CAGR of 9.42% from 2025 to 2032.
• North America will lead with a 36.7% share in 2025, driven by advanced R&D and healthcare systems.
• Asia Pacific will be the fastest-growing region with an estimated CAGR of 11.5% through 2032.
• Oncology will remain the largest therapeutic area, accounting for 44.3% share in 2025.
• Rare diseases will record the fastest growth, with a CAGR of around 16% through 2032.
• Next-generation biologics such as cell and gene therapies and mRNA vaccines represent high-return opportunities.
Market Segmentation
The biological drugs market can be segmented by therapeutic area, with oncology at the forefront, supported by the rising global incidence of cancer and the influx of advanced therapies like immune checkpoint inhibitors and antibody-drug conjugates. The rare diseases segment is anticipated to grow at the fastest pace, bolstered by orphan drug incentives and the increasing number of gene therapy approvals for conditions previously deemed untreatable.
By product type, monoclonal antibodies (mAbs) dominate the market, holding approximately 65% of revenue share in 2025, largely due to their targeted action and efficacy in treating complex conditions such as cancer and autoimmune disorders. Meanwhile, the cell and gene therapy segment is set for exponential growth, driven by CAR-T treatments, CRISPR advancements, and regulatory approvals of transformative therapies like Kymriah and Yescarta.
Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/global-biological-drugs-market.asp
Regional Insights
North America will remain the largest market during the forecast period, reflecting its highly regulated pharmaceutical sector and leadership in early adoption of cutting-edge biotechnologies. The U.S. alone accounts for nearly 89% of North America's biologics market, driven by oncology and immunology therapies.
Asia Pacific is on track to be the fastest-growing region, led by China and India, where robust domestic biopharma industries and favorable government policies are spurring innovation. Increasing access to modern healthcare and the need for affordable biosimilars further bolster the region's prospects.
Market Drivers
The key driver propelling market growth is the rising global burden of chronic and rare diseases. With cancer cases expected to reach 30 million annually by 2030 and autoimmune disorders affecting millions, demand for precision biologics is surging. Advances in gene and cell therapy, monoclonal antibodies, and mRNA vaccines are unlocking new therapeutic possibilities, delivering better efficacy and long-term disease control compared to traditional drugs.
Market Restraints
Despite strong growth prospects, the industry faces significant manufacturing and supply chain challenges. Biologics require complex raw materials, stringent cold chain logistics, and highly specialized production processes. Disruptions in supply chains, as seen during the COVID-19 pandemic, highlight vulnerabilities. Additionally, scaling production capacity to meet growing demand remains difficult and costly, often delaying patient access.
Market Opportunities
A lucrative growth frontier lies in precision medicine and next-generation biologics. Innovations in gene editing, CAR-T therapy, and AI-driven drug design are creating unprecedented opportunities for highly personalized treatment. As regulatory bodies accelerate approvals for orphan drugs and rare disease therapies, biopharma companies can capture high-value niches while expanding global access through biosimilars and modular manufacturing platforms.
Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/2883
Reasons to Buy the Report
• Gain in-depth insights into market growth drivers, restraints, and opportunities shaping the industry.
• Understand detailed segmentation by product type, therapeutic area, and region for strategic planning.
• Access up-to-date forecasts with reliable data on global and regional market size through 2032.
• Identify key players and recent developments in the competitive landscape.
• Leverage actionable intelligence to support investment decisions in next-generation biologics.
Frequently Asked Questions (FAQs)
• How Big is the Biological Drugs Market?
• Who are the Key Players in the Global Biological Drugs Market?
• What is the Projected Growth Rate of the Market?
• What is the Market Forecast for 2032?
• Which Region is Estimated to Dominate the Industry through the Forecast Period?
Company Insights
The competitive landscape is marked by strong participation from global pharmaceutical giants and innovative biotech firms. Key players include:
• Amgen Inc.
• Johnson & Johnson Services, Inc.
• Roche Holding AG
• Pfizer Inc.
• Novartis AG
• AbbVie Inc.
• Bristol-Myers Squibb Company
• Merck & Co., Inc.
• Regeneron Pharmaceuticals, Inc.
• Sanofi S.A.
Recent Developments
• In August 2025, WuXi Biologics' Dundalk site in Ireland received EMA approval for its first commercial biologic launch, boosting flexible global production capacity.
• In June 2025, Innovent Biologics unveiled a dual-innovation oncology strategy focused on next-gen immuno-oncology and antibody-drug conjugates, supported by multi-regional clinical trials.
Conclusion
The biological drugs market is entering a transformative era, reshaping the global pharmaceutical industry with innovative therapies that deliver precision, efficacy, and hope for conditions once considered untreatable. With oncology and rare disease biologics spearheading growth, coupled with the rising adoption of biosimilars and next-generation technologies like CAR-T and mRNA vaccines, the sector is poised for sustained expansion. While supply chain vulnerabilities and high production costs remain pressing challenges, the opportunities in precision medicine and advanced therapeutics far outweigh these hurdles.
North America will continue to dominate the landscape, but the rapid rise of Asia Pacific underscores a broader global shift toward equitable access and affordable biologics. As persistence market research indicates, stakeholders who invest in innovation, scalable manufacturing, and strategic partnerships will be best positioned to capture market share. Ultimately, the biological drugs market is not just a commercial opportunity-it is a pathway to redefining healthcare outcomes for millions worldwide.
Read More Related Reports:
Amyloidosis Therapeutics Market https://www.persistencemarketresearch.com/market-research/amyloidosis-therapeutics-market.asp
Oral Transmucosal Drugs Market https://www.persistencemarketresearch.com/market-research/oral-transmucosal-drugs-market.asp
Fundus Camera Market https://www.persistencemarketresearch.com/market-research/fundus-camera-market.asp
Contract Research Organization Cro Services Market https://www.persistencemarketresearch.com/market-research/contract-research-organization-cro-services-market.asp
Therapeutic Albumin Market https://www.persistencemarketresearch.com/market-research/therapeutic-albumin-market.asp
Contact Us:
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biological Drugs Market to Reach US$452.64 Bn in 2025, Eyes US$1,029.20 Bn by 2032, Says Persistence Market Research here
News-ID: 4171456 • Views: …
More Releases from Persistence Market Research
Robotic Surgery Market to Reach US$41.04 Bn by 2032, Growing at 17.4% CAGR - Per …
The global robotic surgery market is poised for remarkable expansion, with a projected valuation of US$12.93 Bn in 2025 and an anticipated rise to US$41.04 Bn by 2032, reflecting an impressive CAGR of 17.4% during the forecast period. Robotic-assisted surgical systems are redefining modern healthcare by enabling minimally invasive procedures with superior precision, reduced risks, and faster recovery times. According to Persistence Market Research, the adoption of these systems is…
Medical Ultrasound Equipment Market Size Forecasted at US$ 9.9 Bn in 2025, Persi …
The global medical ultrasound equipment market is undergoing steady expansion, fueled by rising chronic disease prevalence, an aging population, and the demand for early, non-invasive diagnostics. According to Persistence Market Research, the market is projected to reach US$ 9.9 billion in 2025 and further expand to US$ 13.2 billion by 2032, growing at a CAGR of 4.2% during the forecast period. With its ability to provide safe, radiation-free, real-time imaging,…
Multi-Lead ECG Machines Market to Reach US$2.4 Billion by 2032, Persistence Mark …
The global multi-lead ECG machines market is entering a transformative phase, with its value projected to rise from US$1.3 billion in 2025 to US$2.4 billion by 2032, growing at a robust CAGR of 9.2%. Multi-lead ECG systems are indispensable for diagnosing and monitoring cardiovascular conditions, forming the backbone of cardiac care in hospitals, clinics, and increasingly, homecare settings. According to Persistence Market Research, the rising burden of heart diseases and…
Fabric Inspection Machine Market Growth Fueled by Textile Industry Expansion and …
Market Overview
The fabric inspection machine market has emerged as a crucial segment of the global textile and apparel industry, playing a vital role in ensuring consistent quality, minimizing defects, and enhancing operational efficiency. These machines are designed to detect weaving faults, knitting defects, color variation, and other quality-related issues before fabrics move to downstream processes. With the textile and apparel industry expanding rapidly across both developed and emerging economies, the…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
